Thomas J Galloway

Thomas J Galloway

Fox Chase Cancer Center - Philadelphia / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 4620350
-
person_outline Thomas J Galloway's MOST POPULAR ARTICLES
1-) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...The Lancet 393 (10166), 40-50, 20198272019
2-) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncologyDG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ...Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 20204272020
3-) Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy …PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ...Journal of Clinical Oncology 32 (34), 3858, 20144222014
4-) Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United StatesCT Murphy, TJ Galloway, EA Handorf, BL Egleston, LS Wang, R Mehra, ...Journal of Clinical Oncology 34 (2), 169-178, 20164142016
5-) NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelinesJJ Caudell, ML Gillison, E Maghami, S Spencer, DG Pfister, D Adkins, ...Journal of the National Comprehensive Cancer Network 20 (3), 224-234, 20223442022